Key Highlights
- Artelo Biosciences will implement a 1-for-9 Reverse Stock Split effective August 31, 2026.
- The split is intended to bolster share price, liquidity, and overall marketability.
- Outstanding common stock will be reduced to approximately 547,774 shares.
- Warrants and Derivatives will be proportionately adjusted per their governing terms; shares closed down 7% at $0.66.
Details of the Reverse Split
Artelo Biosciences Inc. (NASDAQ:ARTL) announced a 1-for-9 reverse stock split, effective August 31, 2026. In a reverse split of this ratio, every nine existing shares are consolidated into one new share, which mechanically raises the per-share price by the same multiple while proportionately reducing the number of shares outstanding — it does not change the underlying value of an investor's holding.
Following the split, Artelo's (NASDAQ:ARTL) outstanding common stock will be reduced to approximately 547,774 shares. The company has also indicated that outstanding warrants and derivative securities will be proportionately adjusted in line with their respective governing terms, keeping the economic terms of those instruments consistent with the new share count.
Why Companies Pursue Reverse Splits
Artelo (NASDAQ:ARTL) described the action as intended to bolster its share price, liquidity, and overall marketability. Reverse splits are a common tool for small-capitalization companies trading at low absolute share prices, since a higher nominal share price can broaden the pool of institutional investors able to hold the stock under internal Investment policies, and can also help a company meet stock exchange minimum bid price requirements where applicable.
What It Means for Shareholders
For existing shareholders, a reverse split changes the number of shares held and the per-share price proportionately, without altering the total value of the position at the time of the split. The practical effects investors typically watch for afterward are changes in trading Liquidity and how the market prices the stock once it trades at a higher nominal level.
Market Reaction
Artelo Biosciences (NASDAQ:ARTL) shares closed down 7% at $0.66 following the announcement.
What is the ratio of Artelo Biosciences' reverse stock split?
Artelo Biosciences (NASDAQ:ARTL) is implementing a 1-for-9 reverse stock split, effective August 31, 2026.
How many shares will be outstanding after the split?
Outstanding common stock will be reduced to approximately 547,774 shares.
Will warrants and derivatives be affected?
Yes, outstanding warrants and derivative securities will be proportionately adjusted per their governing terms.



_11_17_2026_20_37_58_946960.jpg)


Please wait processing your request...